These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

68 related items for PubMed ID: 22226680

  • 1. The effect of pituitary adenylate cyclase-activating polypeptide on elevated plus maze behavior and hypothermia induced by morphine withdrawal.
    Lipták N, Dochnal R, Babits A, Csabafi K, Szakács J, Tóth G, Szabó G.
    Neuropeptides; 2012 Feb; 46(1):11-7. PubMed ID: 22226680
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The effects of pituitary adenylate cyclase-activating polypeptide on acute and chronic morphine actions in mice.
    Mácsai M, Pataki I, Tóth G, Szabó G.
    Regul Pept; 2002 Nov 15; 109(1-3):57-62. PubMed ID: 12409215
    [Abstract] [Full Text] [Related]

  • 4. Obestatin prevents analgesic tolerance to morphine and reverses the effects of mild morphine withdrawal in mice.
    Lipták N, Dochnal R, Csabafi K, Szakács J, Szabó G.
    Regul Pept; 2013 Sep 10; 186():77-82. PubMed ID: 23891980
    [Abstract] [Full Text] [Related]

  • 5. Increased elevated plus maze open-arm time in mice during spontaneous morphine withdrawal.
    Buckman SG, Hodgson SR, Hofford RS, Eitan S.
    Behav Brain Res; 2009 Feb 11; 197(2):454-6. PubMed ID: 18955087
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Afobazole decreases severity of morphine withdrawal syndrome: experimental evidence].
    Konstantinopol'skiĭ MA, Cherniakova IV.
    Eksp Klin Farmakol; 2011 Feb 11; 74(10):12-6. PubMed ID: 22238980
    [Abstract] [Full Text] [Related]

  • 8. Baclofen prevents the elevated plus maze behavior and BDNF expression during naloxone precipitated morphine withdrawal in male and female mice.
    Pedrón VT, Varani AP, Balerio GN.
    Synapse; 2016 May 11; 70(5):187-97. PubMed ID: 26789010
    [Abstract] [Full Text] [Related]

  • 9. Plasma malondialdehyde levels and opiate withdrawal signs observed in rats treated with morphine plus naloxone: effects of alpha-lipoic acid administration.
    Pinelli A, Cighetti G, Trivulzio S.
    Fundam Clin Pharmacol; 2008 Aug 11; 22(4):439-45. PubMed ID: 18705754
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Influence of ATP-dependent K+ channels on nicotine-induced inhibition of withdrawal in morphine-dependent mice.
    Zarrindast MR, Mohajeri S.
    Eur J Pharmacol; 2006 Dec 15; 552(1-3):90-8. PubMed ID: 17049514
    [Abstract] [Full Text] [Related]

  • 12. A comparison of the effects of digoxin, ouabain and milrinone on naloxone-precipitated withdrawal syndrome in mice.
    Bai YL, Chu QJ, Li J, Chen YY, Li WJ, Zhang Q.
    Eur J Pharmacol; 2012 Nov 05; 694(1-3):69-74. PubMed ID: 22960325
    [Abstract] [Full Text] [Related]

  • 13. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
    Rehni AK, Bhateja P, Singh TG, Singh N.
    Behav Pharmacol; 2008 May 05; 19(3):265-9. PubMed ID: 18469544
    [Abstract] [Full Text] [Related]

  • 14. Dansyl-PQRamide, a putative antagonist of NPFF receptors, reduces anxiety-like behavior of ethanol withdrawal in a plus-maze test in rats.
    Kotlinska J, Pachuta A, Bochenski M, Silberring J.
    Peptides; 2009 Jun 05; 30(6):1165-72. PubMed ID: 19463751
    [Abstract] [Full Text] [Related]

  • 15. Quantitation of physical dependence in mice by naloxone-precipitated jumping after a single dose of morphine.
    Smits SE.
    Res Commun Chem Pathol Pharmacol; 1975 Apr 05; 10(4):651-61. PubMed ID: 1171511
    [Abstract] [Full Text] [Related]

  • 16. Mianserin attenuates naloxone-precipitated withdrawal signs in rats acutely or chronically dependent upon morphine.
    Neal BS, Sparber SB.
    J Pharmacol Exp Ther; 1986 Jan 05; 236(1):157-65. PubMed ID: 3001281
    [Abstract] [Full Text] [Related]

  • 17. Diverse effects of intrathecal pituitary adenylate cyclase-activating polypeptide on nociceptive transmission in mice spinal cord.
    Shimizu T, Katahira M, Sugawara H, Inoue K, Miyata A.
    Regul Pept; 2004 Dec 15; 123(1-3):117-22. PubMed ID: 15518901
    [Abstract] [Full Text] [Related]

  • 18. Neuropeptide Y attenuates naloxone-precipitated morphine withdrawal via Y5-like receptors.
    Woldbye DP, Klemp K, Madsen TM.
    J Pharmacol Exp Ther; 1998 Feb 15; 284(2):633-6. PubMed ID: 9454808
    [Abstract] [Full Text] [Related]

  • 19. Antagonism by naloxone of morphine-induced single-dose dependence and antinociception in mice.
    Smits SE.
    Res Commun Chem Pathol Pharmacol; 1976 Dec 15; 15(4):689-96. PubMed ID: 12548
    [Abstract] [Full Text] [Related]

  • 20. Central administration of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide differentially regulates energy metabolism in chicks.
    Tachibana T, Oikawa D, Adachi N, Boswell T, Furuse M.
    Comp Biochem Physiol A Mol Integr Physiol; 2007 May 15; 147(1):156-64. PubMed ID: 17291802
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.